BioPharma Dive August 22, 2023
Inspired by Operation Warp Speed, the new federal program aims to fund development and testing of new therapies that can stay ahead of an evolving virus.
The U.S. government will spend $1.4 billion across a series of contracts to develop new drugs and vaccines for COVID-19, the Department of Health and Human Services announced Tuesday.
The awards represent the first major announcement by “Project NextGen,” a federal program designed to spur newer therapies and protective shots against the coronavirus.
Announced in May, the program is a successor to the “Operation Warp Speed” initiative that helped bring the first COVID vaccines and drugs to market in record time.
Yet Project NextGen has been put together at a time when urgency around...
Today's Sponsors
Today's Sponsor